Hemodynamic theory of progressive renal disease: a 10-year update in brief review (Q40821407)

24 September 2017

1 reference

title

Hemodynamic theory of progressive renal disease: a 10-year update in brief review (English)

1 reference

24 September 2017

1 reference

1 reference

Neuringer JR

1

1 reference

PubMed ID

8322801

24 September 2017

Brenner BM

series ordinal

2

1 reference

24 September 2017

1 July 1993

1 reference

American Journal of Kidney Diseases

24 September 2017

1 reference

24 September 2017

22

1 reference

24 September 2017

98-104

1 reference

24 September 2017

1

1 reference

A simple method of estimating progression of chronic renal failure

24 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Chronic progressive renal disease: rate of change of serum creatinine concentration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Single-nephron pressures, flows, and resistances in hypertensive kidneys with nephrosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Changes of hemodynamics and glomerular ultrafiltration in renal hypertension of rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Hemodynamic basis for glomerular injury in rats with desoxycorticosterone-salt hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Glomerular hemodynamics in experimental diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Prevention of diabetic glomerulopathy by pharmacological amelioration of glomerular capillary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Potential mechanisms mediating postprandial renal hyperemia and hyperfiltration.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Dietary protein restriction in established renal injury in the rat. Selective role of glomerular capillary pressure in progressive glomerular dysfunction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Reversing glomerular hypertension stabilizes established glomerular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Tubuloglomerular feedback and glomerular morphology in Goldblatt hypertensive rats on varying protein diets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Predominance of hemodynamic rather than metabolic factors in the pathogenesis of diabetic glomerulopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Chronic effects of dietary protein in the rat with intact and reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Angiotensin II receptor blockade limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Renal vascular effects of antihypertensive therapy in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effects of nifedipine and enalapril on glomerular structure and function in uninephrectomized SHR.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Short and long term effects of antihypertensive therapy in the diabetic rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Nifedipine versus fosinopril in uninephrectomized diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Anemia lessens and its prevention with recombinant human erythropoietin worsens glomerular injury and hypertension in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Angiotensin converting enzyme inhibition ameliorates glomerular filtration of macromolecules and water and lessens glomerular injury in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Renal effects of calcium antagonists in diabetes mellitus. An overview of studies in animal models and in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

ACE inhibitors in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Nephrotoxic serum nephritis with hypertension: amelioration by antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Glomerular hypertension and injury in desoxycorticosterone-salt rats on antihypertensive therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Renal injury of diet-induced hypercholesterolemia in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Determinants of renal damage in rats with systemic hypertension and partial renal ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effect of heparin on the glomerular structure and function of remnant nephrons

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effects of salt restriction on renal growth and glomerular injury in rats with remnant kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effect of converting enzyme inhibition on the course of adriamycin-induced nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Mechanisms underlying transition from acute glomerular injury to late glomerular sclerosis in a rat model of nephrotic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Is glomerulosclerosis a consequence of altered glomerular permeability to macromolecules?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Evidence against increased glomerular pressure initiating diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effects of dietary protein content in streptozotocin-diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effects of nephron loss on glomerular hemodynamics and morphology in diabetic rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

The solitary kidney: a model of chronic hyperfiltration in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Long-term consequence of nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Focal glomerulosclerosis and proteinuria in patients with solitary kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Clinical features of patients with solitary kidneys

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Focal sclerosis of hypertrophied glomeruli in solitary functioning kidneys of humans

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Mild proteinuria in patients with unilateral kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

No microalbuminuria or other adverse effects of long-standing hyperfiltration in humans with one kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Focal glomerulosclerosis in patients with unilateral nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Prolonged survival with a remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Renal function after tumor enucleation in a solitary kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Progressive renal failure in a remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Progressive renal failure in a patient after one and two-thirds nephrectomy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Long-term follow-up after partial removal of a solitary kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Long-term follow-up of a human subject with a remnant kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Increased kidney size and glomerular filtration rate in early juvenile diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Predicting diabetic nephropathy in insulin-dependent patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Early glomerular hyperfiltration in insulin-dependent diabetics and late nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Increased glomerular filtration rate as a predictor of diabetic nephropathy--an 8-year prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Early glomerular hyperfiltration and the development of late nephropathy in type 1 (insulin-dependent) diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Glomerular hyperfiltration as a risk factor for diabetic nephropathy: five-year report of a prospective study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Follow-up of glomerular hyperfiltration in normoalbuminuric type 1 (insulin-dependent) diabetic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Dietary treatment of chronic renal failure: ten unanswered questions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Angiotensin converting enzyme inhibition and calcium channel blockade in incipient diabetic nephropathy. The Melbourne Diabetic Nephropathy Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Controlled low protein diets in chronic renal insufficiency: meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Low protein diets in chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

The effect of protein restriction on the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Prospective, randomised, multicentre trial of effect of protein restriction on progression of chronic renal insufficiency. Northern Italian Cooperative Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Effect of restricting dietary protein on the progression of renal failure in patients with insulin-dependent diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Protein restriction and renal failure in diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Restriction of dietary protein and progression of renal failure in diabetic nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

The Modification of Diet in Renal Disease Study: Design, Methods, and Results From the Feasibility Study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Progression of renal insufficiency: role of blood pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

Long-term comparison between captopril and nifedipine in the progression of renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2970174-9

7 January 2021

10.1016/S0272-6386(12)70174-9

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

8322801